Nektar Therapeutics NKTR reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:15 PM.
Here's what investors need to know about the announcement.
Earnings
Nektar Therapeutics missed estimated earnings by 28.0%, reporting an EPS of $-0.32 versus an estimate of $-0.25.
Revenue was down $3.23 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.13 which was followed by a 9.42% increase in the share price the next day.
Here's a look at Nektar Therapeutics's past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.45 | -0.45 | -0.94 | -0.68 |
| EPS Actual | -0.32 | -0.31 | -0.85 | -0.49 |
| Revenue Estimate | 22.13M | 22.61M | 22.66M | 24.38M |
| Revenue Actual | 22.02M | 23.62M | 21.59M | 24.82M |
To track all earnings releases for Nektar Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
